Loading clinical trials...
Loading clinical trials...
Determination of Hypoallergenicity of an Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy
Conditions
Interventions
Experimental Extensively Hydrolyzed Formula
Placebo Extensively Hydrolyzed Formula
Locations
8
United States
Children's Hospital Colorado
Aurora, Colorado, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
University of Michigan Food Allergy Clinic
Ann Arbor, Michigan, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Start Date
October 1, 2024
Primary Completion Date
July 1, 2028
Completion Date
January 1, 2029
Last Updated
June 4, 2025
NCT06652698
NCT02405923
NCT02466035
NCT02779881
NCT02379598
NCT01584245
Lead Sponsor
Abbott Nutrition
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions